semaglutide compounding fda enforcement news The has received reports of adverse events after patients used compounded versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved Diabetes advocacy group discourages use

It appears to be far easier to buy a vial

GLP-1 is a relatively new entrant to a weight loss market in the U.S

Now, with Wegovy and Zepbound, were seeing people lose 15-20% of their body weight, which was unheard of before. Despite their effectiveness, GLP-1 medications are not a standalone solution

Cluster 1 included allergies, anxiety, depression, chronic obstructive pulmonary disease, fatigue, fever, hypertension, indigestion, insomnia, gastroesophageal reflux disease, hives, swelling, restlessness, and seizures

The Critical Lean Mass Question The most reassuring finding for body recomposition purposes concerns lean mass preservation